(Q37142971)

English

Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.

scientific article published on 18 April 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

Europe PubMed Central

Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

multiple sclerosis

0 references

Federica Agosta

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Massimo Filippi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

D Bar-Zohar

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

D Goldstaub

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

18 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

719-727

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

FDA: evidentiary standards for drug development and approval

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

MRI relapses have significant pathologic and clinical implications in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Disease-modifying therapy in MS: a critical review of the literature. Part II: Assessing efficacy and dose-response

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Current approved options for treating patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Oral simvastatin treatment in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Baseline MRI predicts future attacks and disability in clinically isolated syndromes.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

The clinico-radiological paradox in multiple sclerosis revisited

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

MRI techniques to monitor MS evolution: the present and the future

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Significance of T2 lesions in multiple sclerosis: A 13-year longitudinal study

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Surrogate endpoints in clinical trials: definition and operational criteria

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

MRI metrics as surrogate markers for clinical relapse rate in relapsing-remitting MS patients

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN β-1b

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

T(1) hypointense lesions in secondary progressive multiple sclerosis: effect of interferon beta-1b treatment

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Measuring brain atrophy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes".

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Axonal transection in the lesions of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Optimizing the association between disability and biological markers in MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brain

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetic resonance spectroscopy in the monitoring of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

The relationship between diffuse axonal damage and fatigue in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

The accuracy of whole brain N-acetylaspartate quantification.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer imaging: practical aspects and clinical applications

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer histogram parameters reflect all dimensions of MS pathology, including atrophy.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Correlation of volumetric magnetization transfer imaging with clinical data in MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer can predict clinical evolution in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Role of magnetic resonance imaging in the diagnosis and monitoring of multiple sclerosis: consensus report of the White Matter Study Group.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer ratio in new MS lesions before and during therapy with IFNbeta-1a

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

The effect of interferon beta-1b on quantities derived from MT MRI in secondary progressive MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cord.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Diffusion tensor MRI in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Cortical lesions and brain atrophy in MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Evidence for progressive gray matter loss in patients with relapsing-remitting MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Thalamic Involvement in Multiple Sclerosis: A Diffusion‐Weighted Magnetic Resonance Imaging Study

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Correlates of MS disability assessed in vivo using aggregates of MR quantities.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Imaging spinal cord damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetisation transfer ratio measurement in the cervical spinal cord: a preliminary study in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Associations between cervical cord gray matter damage and disability in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Quantification of cervical cord pathology in primary progressive MS using diffusion tensor MRI.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Voxel-based analysis of MTR images: a method to locate gray matter abnormalities in patients at the earliest stage of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Cladribine and progressive MS: Clinical and MRI outcomes of a multicenter controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Magnetization transfer imaging to monitor the evolution of MS: A 1-year follow-up study

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

European Study on Intravenous Immunoglobulin in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Diffusion tensor magnetic resonance imaging in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

A composite score to predict short-term disease activity in patients with relapsing-remitting MS

1 reference

https://api.crossref.org/works/10.1177%2F1352458507088102

21 January 2018

Identifiers

10.1177/1352458507088102

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18424478%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37142971&oldid=1379469585"